Ostatné · DHR
Danaher Corporation
Fundamenty firmy Healthcare · Diagnostics & Research · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 22 hodnotení
silný nákup
- Najnižší cieľ
- 200,00
- Priemerný cieľ
- 236,32
- Najvyšší cieľ
- 310,00
- Potenciál
- +8,4 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | 1,91 | 1,83–1,99 | 1,89 | +1,2 % |
| budúci štvrťrok | 2,58 | 2,48–2,63 | 2,23 | +15,9 % |
| tento rok | 8,51 | 8,45–8,55 | 7,80 | +9,1 % |
| budúci rok | 9,30 | 9,12–9,50 | 8,51 | +9,3 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 6,6 mld. | 6,1 mld. | +8,3 % |
| budúci štvrťrok | 7,6 mld. | 6,8 mld. | +10,8 % |
| tento rok | 26,3 mld. | 24,6 mld. | +7,2 % |
| budúci rok | 28,5 mld. | 26,3 mld. | +8,1 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Blair Rainer MChief Executive Officer | predaj | 12,7 mil. | 21.08. |
| Riley Christopher PaulOfficer | odmena v akciách | – | 04.08. |
| Gutierrez-Ramos Jose-CarlosOfficer | odmena v akciách | – | 04.08. |
| Milosevich Gregory MOfficer | odmena v akciách | – | 04.08. |
| Rales Steven MChairman of the Board | odmena v akciách | – | 04.08. |
| Rales Mitchell POfficer and Director | odmena v akciách | – | 04.08. |
| Filler LindaDirector | uplatnenie opcií | 237 060 | 15.07. |
| Zerhouni Elias ADirector | uplatnenie opcií | 237 060 | 15.07. |
| Dewan FerozDirector | odmena v akciách | – | 15.05. |
| Zerhouni Elias ADirector | odmena v akciách | – | 15.05. |
| List-Stoll Teri L.Director | odmena v akciách | – | 15.05. |
| Sanders A.shaneDirector | odmena v akciách | – | 15.05. |
Kto vlastní akcie
Slávni investori: Dan Loeb · 2.2 % Chase Coleman · 0.4 % · nový Stanley Druckenmiller · 0.2 % · nový Bill Gates · 0.2 % Ray Dalio · 0.0 %
Blackrock Inc.7,84 %
Vanguard Capital Management LLC5,89 %
FMR, LLC4,20 %
State Street Corporation4,05 %
Wellington Management Group, LLP2,32 %
Capital International Investors2,21 %
Geode Capital Management, LLC2,03 %
Vanguard Portfolio Management LLC2,02 %
O firme (popis z Yahoo Finance, anglicky)
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
📅 Výsledky hospodárenia: Streda 21. 10. · odhad EPS 1,91
Technické signály
- Rastový trend – Kurz nad SMA50 aj SMA200, SMA50 nad SMA200
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou DHR.